Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
242 participants
INTERVENTIONAL
2016-09-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Fiber Rye Foods for Body Weight and Body Fat Reduction
NCT04203758
The Effects of Rye Crisp Bread on Appetite and Metabolic Function
NCT02011217
The Effect of Dietary Fibre and Plant Protein on Appetite and Metabolic Function
NCT01965210
Effect of Rye Bread Breakfasts on Eight Hour Satiety Ratings
NCT00876785
Effects of Whole Grain on Weight Maintenance
NCT01239147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wholegrain rye
Wholegrain rye products with a high content of dietary fiber
Wholegrain rye
Cereal products based on wholegrain rye
Refined wheat
Refined wheat products with a low content of dietary fiber
Refined wheat
Cereal products based on refined wheat
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wholegrain rye
Cereal products based on wholegrain rye
Refined wheat
Cereal products based on refined wheat
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hb≥120g/l
* Serum thyroid stimulating hormone (TSH) ≤4.00 mIU/L
* Plasma low density lipoprotein cholesterol \<5.3 mmol/L
* Plasma triglycerides ≤1.8 mmol/L
* Signed informed consent
* Freezer capacity for 2 weeks bread provision
Exclusion Criteria
* Unable to complete satisfactorily the 3-day weighted food record at screening visit 2.
* Unable to lose 0.5 kg or more during the run-in period for men and women not having menstruation during the run in period
* Increased body weight, despite reported adherence to dietary intake for women with menstruation during the run-in period.
* Using nicotine products on a daily basis (incl. chewing gum, patches, snus etc.)
* Using e-cigarettes (regardless of nicotine content)
* Following any weight reduction program or having followed one during the last 6 months prior to visit 1
* Diastolic blood pressure 105 mm Hg at visit 1
* Systolic blood pressure 160 mm at visit 1
* History of stomach or gastrointestinal conditions (Inflammatory bowel disease, Crohn's disease, malabsorption, colostomy, bowel resection, gastric bypass surgery etc.)
* More than 10 hours physical activity per week
* History of heart failure or heart attack within 1 year prior to screening
* Have type I diabetes
* Receiving pharmacological treatment for type II diabetes (treatments based on life style interventions are acceptable, as long as they are compatible with the study protocol)
* Previous gastrointestinal surgery
* Thyroid disorder
* History of drug or alcohol abuse
* Stroke or transient ischemic attack (TIA) within 1 year prior to screening
* Consumption of drugs aimed at weight management or drugs affecting body weight to a degree that is considered unsuitable for study participation by responsible physician (will be included in the list of allowed/disallowed medications)
* Pregnant or lactating or wish to become pregnant during the period of the study.
* Food allergies or intolerances
* Vegetarian (due to the standardized meals for appetite measurements)
* Unable to understand written and spoken Swedish
* Lack of suitability for participation in the trial, for any reason, as judged by the medical doctor or PI.
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swedish University of Agricultural Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Rikard Landberg
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rikard Landberg, Dr
Role: PRINCIPAL_INVESTIGATOR
Chalmers University of Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chalmers University of Technology
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Iversen KN, Carlsson F, Andersson A, Michaelsson K, Langton M, Riserus U, Hellstrom PM, Landberg R. A hypocaloric diet rich in high fiber rye foods causes greater reduction in body weight and body fat than a diet rich in refined wheat: A parallel randomized controlled trial in adults with overweight and obesity (the RyeWeight study). Clin Nutr ESPEN. 2021 Oct;45:155-169. doi: 10.1016/j.clnesp.2021.07.007. Epub 2021 Jul 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SLU254
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.